tiprankstipranks
DexCom Launches G7 System in Key Markets Across Europe and Asia
Market News

DexCom Launches G7 System in Key Markets Across Europe and Asia

Medical devices provider DexCom (NASDAQ:DXCM) has launched its continuous glucose monitoring system DexCom G7 across the U.K., Ireland, Germany, Austria, and Hong Kong.

DXCM also plans to introduce the product in New Zealand and South Africa in the coming weeks. The device sends real-time glucose data to a receiver without the need for finger sticks or scanning.

Further, the company is also working with insulin pump partners to integrate the device with present and future automatic insulin delivery systems.

Is DXCM Stock a Buy, Sell, or a Hold?

DXCM stock has gained nearly 11% over the past five days, and Wall Street sees a further 9.63% upside potential in the stock based on an average price target of $99.38 alongside a Strong Buy consensus rating.

The consensus rating for DXCM is based on 13 Buys and one Hold rating at present.

Disclosure

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles